Zobrazeno 1 - 10
of 32
pro vyhledávání: '"C17 20 lyase"'
Autor:
Johan Wouters, Mihály Szécsi, Rita Skoda-Földes, Gábor Mikle, Lilla Maksó, László Kollár, Bianka Edina Herman, Eszter Szánti-Pintér, Ágnes Gömöry
Publikováno v:
Steroids. 123:61-66
Aza-Michael addition of 16-dehydropregnenolone was studied in the presence of a basic ionic liquid, [DBU][OAc] as catalyst and solvent. The reaction was carried out using different primary and secondary amines as N-nucleophiles. The products were obt
Autor:
János Wölfling, Mihály Szécsi, Dóra Kovács, Éva Frank, Ida Kovács, István Zupkó, Nikoletta Szabó
Publikováno v:
European Journal of Medicinal Chemistry. 70:649-660
Novel 17-exo-oxadiazoles in the androst-5-ene series were efficiently synthesized in a two-step sequence via the corresponding O-acylamidoxime intermediates (obtained from steroidal 17-carboxylic acids and amidoximes in the presence of coupling reage
Publikováno v:
Tetrahedron: Asymmetry. 15:2021-2028
An asymmetric synthesis of the selective C 17,20 -lyase inhibitor 2 has been established in eight steps from 2,3-dihydroxynaphthalene 9 . The key steps are the enantioselective oxidation of ketone 17 to the chiral α-hydroxy ketone 18 and the diaster
Publikováno v:
Tetrahedron: Asymmetry. 15:1555-1559
An efficient stereocontrolled synthesis of the potent C17,20-lyase inhibitor, (1S)-1-(1H-imidazol-4-yl)-1-(6-methoxy-2-naphthyl)-2-methyl-1-propanol 1, has been established. The stereogenic center of 1 was successfully constructed by a highly diaster
Autor:
Rolf W. Hartmann, Samer Haidar
Publikováno v:
Archiv der Pharmazie. 335:526-534
17 alpha-hydroxylase-C17, 20-lyase (P450 17, CYP 17) is a key enzyme in androgen biosynthesis and a target for the treatment of prostate cancer. In order to find novel inhibitors for this enzyme, several compounds bearing different moieties able to c
Publikováno v:
Bioorganic & Medicinal Chemistry. 4:1411-1420
Steroids bearing a heteroaromatic substituent at C-17 were designed as inhibitors of C 17(20) lyase. The thiazoles, furans, and thiophenes appended to the steroid nucleus were positioned on the α-face and the β-face of the steroid, and conjugated w
Autor:
M Jarman, S E Barrie
Publikováno v:
Endocrine Related Cancer. 3:25-39
Autor:
Angela L. Marquart, Marie E. Laughlin, Norton P. Peet, Cynthia A. Gates, Thomas R. Blohm, Philip M. Weintraub, Michael R. Angelastro
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 6:97-100
Androstenes bearing a cyclopropyl group attached to the C-17β position with a heteroatom linker, designed as mechanism-based inhibitors of steroid C 17(20) lyase, were found to be potent, time-dependent inhibitors of this enzyme.
Autor:
Charles A. Laughton, C. F. Snook, David F. Burke, Michael Jarman, Gerard A. Potter, Stephen Neidle
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:1125-1130
17-(3-pyridyl)androsta-5,16-dien-3β-ol, a nanomolar inhibitor of the P450 enzyme C17α-hydroxylase/C17-20 lyase, is a target for prostate cancer chemotherapy. A model is presented for the inhibitor docked into the structure of the enzyme.
Publikováno v:
The Showa University Journal of Medical Sciences. 7:207-213